Equities Lead Investor Sentiments: Coverage Initiated on AMETEK, FedEx, MacroGenics, Walgreens and Apple

NEW YORK, December 23, 2014 /PRNewswire/ --

Moments ago, Analysts Review released new research updates concerning several important developing situations including AMETEK (NYSE: AME), FedEx (NYSE: FDX), MacroGenics (NASDAQ: MGNX), Walgreens (NYSE: WAG), and Apple (NASDAQ: AAPL). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.

To access our full PDF reports on a complementary basis, please visit the links below.

--

Today's update concerns the following companies:

============

Full PDF Download Links (you may have to copy and paste the following links into your browser):

AME Research Report: ( http://get.analystsreview.com/pdf/?c=AMETEK&d=23-Dec-2014&s=AME ),

FDX Research Report: ( http://get.analystsreview.com/pdf/?c=FedEx&d=23-Dec-2014&s=FDX ),

MGNX Research Report: ( http://get.analystsreview.com/pdf/?c=MacroGenics&d=23-Dec-2014&s=MGNX ),

WAG Research Report: ( http://get.analystsreview.com/pdf/?c=Walgreens&d=23-Dec-2014&s=WAG ),

AAPL Research Report: ( http://get.analystsreview.com/pdf/?c=Apple&d=23-Dec-2014&s=AAPL ).

============

--

Analyst Update: Holiday Season Preparations, Pricing Updates, Upcoming Earnings, and Agreements

Reviewed by: Rohit Tuli, CFA®  

The U.S. stock market on Monday booked its fourth straight day of gains as S&P 500 and Dow Jones Industrial Average (DJIA) closed at new records. The rally in U.S. markets was fueled by continued hopes that the Federal Reserve wouldn't be in a rush to raise interest rates. The S&P 500 gained 0.38%, DJIA advanced 0.87%, and the Nasdaq moved up 0.34% at the close of the session. The European markets also ended the day in green, rising for the fifth session in a row, with Greek shares boosted by the Prime Minister's offer to bring pro-European independents into the government. The Asian stocks were mostly higher on Monday as steadiness in crude oil prices and the Russian ruble, along with the Federal Reserve's indication that it will take a slow approach to raising interest rates, lifted the market sentiments.

Shares of AMETEK, Inc. (AMETEK) ended the December 22, 2014 trading session at $53.14, up 1.49%. The stock rose for the sixth consecutive session and has gained 9.4%, outperforming the NYSE Composite, which returned 4% during the same time period. The stock is trading near its 52-week high of $54.50. A further detailed analysis of the financial statements and latest developments is available in our research report on AMETEK.

FedEx Corporation's (FedEx) shares continue their uptrend as the Company battles unruly weather, amidst ongoing holiday shopping. The Company recently announced its Q2 FY 2015 earnings, which missed analyst estimates, even though the Company backed its full-year FY 2015 guidance. Read our research report on FedEx to know more about the latest results and the preparations for the ongoing holiday season.

MacroGenics Inc. (MacroGenics) announced collaboration and license agreement with Janssen to Develop MGD011 for Multiple B-Cell Malignancies; Stock up almost 12% in trade. MGD011, a humanized CD19 x CD3 bispecific DART protein, is being developed for the treatment of B-cell hematological malignancies. Read more about the terms of the agreement, right here at Analysts Review.

Walgreen Co. (Walgreens) set to announce Q1 FY 2015 earnings results at 7:30 a.m. ET on December 23, 2014. The Company will also hold a conference call with Walgreens management beginning at 8:30 a.m. ET.  As per Zacks investment research data, the consensus EPS estimate is of 74 cents. Read more about Walgreens' upcoming results, analyst estimates, and latest news.

Apple Inc. (Apple) up almost 1% in trade as stocks world over enjoy 'santa rally'. Shares of the California-based Company have gained 5.8% in the last four trading sessions. Meanwhile, Apple resumed iPhone sales in Russia with increased pricing. How Apple is tackling the yo-yoing Russian Ruble? Read our research report to know more.

--

About Analysts Review  

At Analysts Review, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

Analysts Review was designed for investors. By providing the best information available, we have set ourselves apart as one of the premier online investor communities.

--

Editor Note: This is not company news. We are an independent source and our views do not reflect the companies mentioned.

Compliance Procedure: Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA®. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

Further Resources: For more information about this release including editorial notes, compliance procedures and legal disclosures, please visit: http://www.analystsreview.com/editors

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review